Author information:
(1)Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, 
Israel.
(2)Melanoma Institute Australia, Sydney, New South Wales, Australia.
(3)Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, 
New South Wales, Australia.
(4)National Human Genome Research Institute, US National Institutes of Health, 
Bethesda, Maryland, USA.
(5)National Cancer Institute, US National Institutes of Health, Bethesda, 
Maryland, USA.
(6)Institute of Biochemistry, Food Science and Nutrition, Hebrew University, 
Rehovot, Israel.
(7)Department of Biological Services, Weizmann Institute of Science, Rehovot, 
Israel.
(8)QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
(9)Department of Biological Regulation, Weizmann Institute of Science, Rehovot, 
Israel.
(10)Centre for Cancer Research, Westmead Millennium Institute for Medical 
Research, University of Sydney, Sydney, New South Wales, Australia.
(11)Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, 
Sydney, New South Wales, Australia.